HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Free Full Text (PDF) Free All Versions of this Article: 104/5/1504    most recent 00861.2007v1 Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kalinowski, L. Articles by Sinusas, A. J. Search for Related Content PubMed PubMed Citation Articles by Kalinowski, L. Articles by Sinusas, A. J.

INNOVATIVE METHODOLOGY

Targeted imaging of hypoxia-induced integrin activation in myocardium early after infarction

¹Experimental Nuclear Cardiology Laboratory, Division of Cardiovascular Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut; ²Department of Clinical Chemistry and Biochemistry, Medical University of Gdansk, Gdansk, Poland; and ³Departments of Pathology and ⁴Diagnostic Radiology, Yale University School of Medicine, New Haven, Connecticut

Submitted 10 August 2007 ; accepted in final form 5 March 2008

The vβ3-integrin is expressed in angiogenic vessels in response to hypoxia and represents a potential novel target for imaging myocardial angiogenesis. This study evaluated the feasibility of noninvasively tracking hypoxia-induced vβ3-integrin activation within the myocardium as a marker of angiogenesis early after myocardial infarction. Acute myocardial infarction was produced by coronary artery occlusion in rodent and canine studies. A novel ¹¹¹In-labeled radiotracer targeted at the vβ3-integrin (¹¹¹In-RP748) was used to localize regions of hypoxia-induced angiogenesis early after infarction. In rodent studies, the specificity of ¹¹¹In-RP748 for vβ3-integrin was confirmed with a negative control compound (¹¹¹In-RP790), and regional uptake of these compounds correlated with ²⁰¹Tl perfusion and a ^99mTc-labeled nitroimidazole (BRU59-21), which was used as a quantitative marker of myocardial hypoxia. The ex vivo analysis demonstrated that only ¹¹¹In-RP748 was selectively retained in infarcted regions with reduced ²⁰¹Tl perfusion and correlated with uptake of BRU59-21. In canine studies, myocardial uptake of ¹¹¹In-RP748 was assessed using in vivo single-photon-emission computed tomography (SPECT), ex vivo planar imaging, and gamma well counting of myocardial tissue and correlated with ^99mTc-labeled 2-methoxy-2-methyl-propyl-isonitrile (^99mTc-sestamibi) perfusion. Dual-radiotracer in vivo SPECT imaging of ¹¹¹In-RP748 and ^99mTc-sestamibi provided visualization of ¹¹¹In-RP748 uptake within the infarct region, which was confirmed by ex vivo planar imaging of excised myocardial slices. Myocardial ¹¹¹In-RP748 retention was associated with histological evidence of vβ3-integrin expression/activation in the infarct region. ¹¹¹In-RP748 imaging provides a novel noninvasive approach for evaluation of hypoxia-induced vβ3-integrin activation in myocardium early after infarction and may prove useful for directing and evaluating angiogenic therapies in patients with ischemic heart disease.

angiogenesis; radiotracer imaging; myocardial infarction

This article has been cited by other articles:

				A. J. Sinusas Targeted imaging offers advantages over physiological imaging for evaluation of angiogenic therapy. J. Am. Coll. Cardiol. Img., July 1, 2008; 1(4): 511 - 514. [Full Text] [PDF]